DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapidaortic stenosissystolic murmurTAVISAVRsyncopeheart valve disease

Aortic stenosis

Essential points for quick revision.

!
Escalate

Call 999 for syncope with ongoing compromise, new chest pain at rest, severe breathlessness, pulmonary oedema or shock. Acute decompensation in severe aortic stenosis needs monitored specialist care because hypotension and abrupt preload reduction may be poorly tolerated.

Synopsis

Recognise severe aortic stenosis, distinguish high-gradient from low-flow disease, and choose surveillance, urgent stabilisation and valve-team referral routes in UK practice.

  • The classic symptoms are exertional breathlessness, angina and syncope; any symptom attributable to severe stenosis changes prognosis and prompts intervention assessment.
  • The murmur is harsh, ejection systolic and usually radiates to the carotids; a slow-rising low-volume pulse and soft second heart sound support advanced disease.
  • Severe high-gradient stenosis is usually Vmax 4.0 m/s or more, mean gradient 40 mmHg or more, or valve area 1.0 cm2 or less, interpreted together rather than in isolation.

Key red flags

Heart-failure phenotype

Orthopnoea, crackles, raised JVP and oedema suggest decompensation and require urgent assessment rather than routine surveillance.

Investigation priorities

01
Transthoracic echocardiographyFirst step

Define valve anatomy, Vmax, mean gradient, valve area, LVEF, stroke volume, other valves and aortic dimensions.

Management branches

symptomaticSymptomatic severe aortic stenosis

Severe stenosis is accompanied by exertional dyspnoea, angina, syncope or heart failure not better explained otherwise.

  1. Confirm symptom–valve concordance and severity promptly with specialist echocardiography; do not wait for the next surveillance scan.
  2. Refer to a multidisciplinary heart valve team for intervention assessment and evaluate frailty, comorbidity, coronary/aortic anatomy and procedural risk.

Key medicines

FurosemideFor acute oedema, 20–50 mg IV initially; inject slowly and do not exceed 4 mg/min. Reassess before any repeat dose.
Open full textbook Answer 2 questionsCardiology check
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom